ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹64 Cr | ₹54 Cr | ₹28 Cr | ₹25 Cr | ₹20 Cr |
What is the latest Contingent Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹64 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹28 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹20 Cr |
How is Contingent Liabilities of ERIS LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹64 Cr | 19.17 | |
| Mar2024 | ₹54 Cr | 90.05 | |
| Mar2023 | ₹28 Cr | 15.82 | |
| Mar2022 | ₹25 Cr | 25.02 | |
| Mar2021 | ₹20 Cr | - | |
Compare Contingent Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹19,847.5 Cr | 1.4% | 2.6% | -10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 1.4% |
2.6% |
-10.6% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses